Posting this under the heading it deserves: Micro-titration: a disputed topic, argued properly — one year on Everything below is what sits behind that.
Reading back through what has been written here about Micro-titration, three questions come up every time and only one has ever been answered properly.
Listing all three, with what I think the state of the answer is for each, so the thread can start further along than the last one did.
The confident answers on Micro-titration and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day of each week.
Take the reasoning and check the arithmetic; I do not always get it right.
Before the thread moves on from Micro-titration — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and from an n of four hundred.
I had read the opposite somewhere and cannot now find where, which tells me something.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been studied clinically. One mg of semaglutide is not equivalent to one mg of something else in any meaningful sense.
I have changed my mind on this once already, so take it as current rather than settled.
I disagree with the framing of Micro-titration above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.
The reasoning depends on an assumption that is doing a lot of work and is never stated. If the assumption holds, the conclusion follows. I do not think it holds generally.
Post #9 put the caveat in the right place and I want to underline it.
The number people quote for Micro-titration is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on its own.
The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you are assessing a stable concentration rather than a rising one.
Scoping that to what I have actually seen rather than what I have read.
The arithmetic in post #13 is right; the assumption feeding it is the part to check.
Reading this Micro-titration thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
No disagreement from me. Posting only so the question does not look ignored.
Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by real-world reports. The dose does not seem to stop working, but the longest trials are not indefinitely long.
Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a good one.
Adding a small correction to the Micro-titration summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
This follows post #17 rather than contradicting it.
Micro-titration is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat it as one.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
That is the practical version. The rigorous version is longer and says the same thing.
Post #20 describes the usual case. This is about the unusual one.
Agreed on Micro-titration, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the starting assumption is the part nobody states.
Confirming post #22 from a second method, which matters more than confirming it from a second person.
Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that very small increments are hard to measure accurately with a syringe.
A guess, clearly labelled as one.
Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by real-world reports. The dose does not seem to stop working, but the longest trials are not indefinitely long.
Post #26 is right about the mechanism and I think understates the practical bit.
On Micro-titration: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here including this one.
Coming back to post #28, because the follow-up matters more than the original answer.
Answering the Micro-titration question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken.